Iowa 2014 pharmacy law EXAM
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
|---|---|---|---|---|---|
| Display of license - what is required? | show 🗑
|
||||
| What info is available for public inspection for each person licensed by the board? | show 🗑
|
||||
| Family planning clinic - is it regulated by Iowa code (155a)? | show 🗑
|
||||
| Control substance -definition | show 🗑
|
||||
| show | Pharmacist designated on a pharmacy license as the pharmacist who has the authority and responsibility for the pharmacy's compliance with the laws and rules pertaining to the practice of pharmacy
🗑
|
||||
| show | 1.apply to the board-subject to approval
2.register during training
3.must meet standards - registrations may be revoked, suspended or denied if in violation of the laws in any state relating to prescription drugs, controlled substances or non rx drugs.
🗑
|
||||
| Pharmacist-intern - definition | show 🗑
|
||||
| show | any pharmacist licensed to practice pharmacy whose license is current and in good standing.
🗑
|
||||
| show | no
🗑
|
||||
| show | 1.licensed pharmacist
2. responsible for initialing and dating competencies obtained by intern and for completing affidavits for number of hours and dates for intern's training
3. responsible for all functions performed by intern
🗑
|
||||
| how many interns may preceptor supervise concurrently? | show 🗑
|
||||
| show | establish competency and identification,tracking and disciplinary action for violations
🗑
|
||||
| who is ultimately responsible for the actions of a pharmacy tech? | show 🗑
|
||||
| show | complete application for registration within 30 days of accepting employment in an Iowa pharmacy (board shall receive an application before 30 days expire)
🗑
|
||||
| technician training | show 🗑
|
||||
| show | 12 month to complete ICPT or PTCB Pharmacy Technician Certification Board (PTCB ) and the Institute for the Certification of Pharmacy Technicians (ICPT).
🗑
|
||||
| pharmacist license - components | show 🗑
|
||||
| show | The NDC is a unique 10-digit identifier assigned to each medication. It has 3 segments: The Labeler code identifies the company that manufactures or distributes the drug. The Product segment identifies the strength, dosage form, and formulation. The Packa
🗑
|
||||
| show | Orphan drugs are for rare diseases, which means the disease effects less than 200,000 people in the US. The Orphan Drug Act of 1983 is meant to encourage companies to development drugs for these diseases.
🗑
|
||||
| purpose of Phase 3 clinical studies | show 🗑
|
||||
| A drug is found to be under-strength, although it is not used to treat a life-threatening disease. What type of recall will be required? | show 🗑
|
||||
| show | It is legally owned by the pharmacy and should not be given to the patient. A copy of the prescription should be offered if the patient requests it.
🗑
|
||||
| show | The excipient is the inactive substance that carries the active ingredients, and they do not need to be identical for a drug to be a pharmaceutical equivalent.
🗑
|
||||
| Which of the following would not be a privacy violation under HIPPA? I. Leaving message re:rx with the patient's spouse. II. Allowing a pharm sales rep to review patient's rx files III. Mailing a prescription reminder to a patient in a sealed envelope. | show 🗑
|
||||
| there is evidence that a new drug could create a risk to the human fetus based on investigational studies. However,benefits of the drug may justify use of the drug in pregnant women despite risks. What pregnancy category would this drug be classified in? | show 🗑
|
||||
| show | Schedule I controlled substances are those with a high potential for abuse, no accepted medical use, and a lack of accepted safety information.
🗑
|
||||
| show | anabolic steroids and marinol(Morphine is a Schedule II controlled substance)
🗑
|
||||
| tech check tech program | show 🗑
|
||||
| show |
Required hours of internship
1500 hours total:
1250 hours - college based clinical program
250 hours - under the supervision of a preceptor in a licensed pharmacy
🗑
|
||||
| show | Permanent closing
Change of ownership,location,pic
Sale/transfer of drugs on closing/change ownership
Change of legal name
Theft or significant loss of controlled
Disasters etc affecting strength, purity, or labeling of drugs, medications, devices,
🗑
|
||||
| show | A pharmacist shall report in writing to the board within 10 days a change of name, address, or place of employment
🗑
|
||||
| notification to the board : wholesaler | show 🗑
|
||||
| validity of rx based on: | show 🗑
|
||||
| show | The date of issue
Name and address of patient
Name, strength, and quantity of drug, medicine, or device
Directions for use
Name, address, and written signature of practitioner
DEA # if controlled substance
🗑
|
||||
| What additional items are required on a faxed prescription? | show 🗑
|
||||
| What 2 items are not required on an oral prescription called in? | show 🗑
|
||||
| show | 12 refills during 18 month (in practice- only 12 month)
🗑
|
||||
| show | rxt is unable to contact MD with reasonable effort
may create patient suffering
RXT informs the patient or the patient's agent at the time of dispensing, and the practitioner re: reauthorization is required
rx may be refilled once till authorization
🗑
|
||||
| CS : SCHEDULES FIORINAL | show 🗑
|
||||
| show | UP TO 60 DAYS IF PATIENT IS IN LTCF OR TERMINALLY ILL .
DOCUMENT DATE, QTY DISPENSED , QTY REMAINING, ID OF DISPENSING PHARMACIST ON THE BACK OF RX
🗑
|
||||
| show | UP TO 72HRS - IF LATER- OBTAIN NEW RX
🗑
|
||||
| show | ONLY IF PHARMACY CLOSED
ONLY AUTHORIZED PERSON
WRITTEN DR ORDER PLACED INSIDE
LOG MAINTAINED
🗑
|
||||
| show | Yes (ephedrine, PSE, and PPA are schedule V)
🗑
|
||||
| show |
18 months non-CS , 6 months limit on rx in controlled substance C-III to C-V
C-II- NA
🗑
|
||||
| Does state allow sale of C-V preps OTC? | show 🗑
|
||||
| show | Yes- C-II to C-IV
🗑
|
||||
| Marijuana schedule | show 🗑
|
||||
| show | Dronabinol (Tetrahydrocannabinol (THC) )
C-III (state)
🗑
|
||||
| Ephedrine, phenylpropanolamine, pseudoephedrine CS SCHEDULE? ELECTRONIC REAL TIME RECORDS? | show 🗑
|
||||
| show | 3600 MG IN 24HRS
1 PACKAGE IN 24 HRS
7500 MG IN 30DS
🗑
|
||||
| show | Purchaser must be at least 18 years of age and present a government‐issued photo ID, including proof of age
Pharmacist is responsible for verifying name and that photo on the ID matches the purchaser
🗑
|
||||
| RESTRICTIONS ON SALE Ephedrine, phenylpropanolamine, pseudoephedrine -CAN MORE THAN 7500 MG BE SOLD IN 30DS? | show 🗑
|
||||
| Ephedrine, phenylpropanolamine, pseudoephedrine | show 🗑
|
||||
| Ephedrine, phenylpropanolamine, pseudoephedrine PTS PRINT OUT AVAILABLE? | show 🗑
|
||||
| CS registration | show 🗑
|
||||
| show | C-IV
🗑
|
||||
| Lomotil (diphenoxylate w/ atropine) Promethazine/codeine elixir(PHENERGAN) | show 🗑
|
||||
| CAN C-II RXS BE FAXED TO PHARMACY? | show 🗑
|
||||
| show | 1. Narcotic CII to be compounded for direct parenteral (IV, IM, SC, epidural) administration to
a patient
2. For resident of a long‐term care facility
3. For a hospice patient
🗑
|
||||
| adding 1000 mg of codeine to tylenol with codeine compound 120/12mg/5ml makes final mix schedule ... | show 🗑
|
||||
| show | OBRA-90 -DOCUMENT SUCH REFUSAL , NO OBLIGATION TO COUNSEL IF DOCUMENTED REFUSAL
🗑
|
||||
| MID LEVEL PRACTITIONERS ARE.. | show 🗑
|
||||
| C-V | show 🗑
|
||||
| C-V | show 🗑
|
||||
| C-V | show 🗑
|
||||
| C-V | show 🗑
|
||||
| OTC SALE OF C-V: QTY,WHO? | show 🗑
|
||||
| show | CODEINE CONTAINING (ROBITUSSIN AC ) MAX 4OZ=120ML IN 48HRS
🗑
|
||||
| morphin-CS? | show 🗑
|
||||
| show | PHARMACY MAY SEND AT ANY TIME TO REVERSE DISTRIBUTOR,
REVERSE DISTRIBUTOR MUST ISSUE DEA-222 FORM TO PHARMACY
🗑
|
||||
| DEA-41 FORM | show 🗑
|
||||
| show | NAME,DOSAGE FORM,STRENGTH, QUANTITY, DATE WHEN SENT to reverse distributor
🗑
|
||||
| show | ONCOLOGY AND HAZARDOUS -COMPOUNDED UNDER VERTICAL LAMINAR FLOW IN CLASS II BIOLOGY SAFETY CABINET
🗑
|
||||
| show | TREATMENT OF ADDICTION/PRESCRIBING CS C-II (IE METHADONE) APPLICANT FILLS DEA FORM 363
🗑
|
||||
| TO PROVIDE MAINTENANCE AND ADDICTION TREATMENT PRESCRIBER MUST: | show 🗑
|
||||
| PRESCRIBE CS CIII-V FOR ADDICTION TREATMENT DR.MUST: | show 🗑
|
||||
| BUPRENEX USE : | show 🗑
|
||||
| 3-DAY RULE (OR 72 HOUR RULE) | show 🗑
|
||||
| show | PATIENT MUST BE REGISTERED IN ADDICTION TREATMENT PROGRAM
🗑
|
||||
| REFILLS | show 🗑
|
||||
| show | CONTINUOUS QUALITY IMPROVEMENT PROGRAM
🗑
|
||||
| show | INCORRECT DRUG
INCORRECT DRUG STRENGTH
INCORRECT DOSAGE FORM
DRUG RECEIVED BY WRONG PATIENT
INADEQUATE OR INCORRECT PACKAGING, LABELING OR DIRECTIONS
ANY INCIDENT RELATED TO RX DISPENSED THAT HAS POTENTIAL TO RESULT IN SERIOUS HARM TO THE PATIENT
🗑
|
||||
| show | EACH PHARMACY AND PIC - POLICIES AND PROCEDURES ,TRAINING ,ANALYZING DATA COLLECTED - AN MIN ANNUAL MEETING WITH RELATED PERSONNEL
🗑
|
||||
| show | PERSONNEL TRAINED TO INFORM PHARMACIST ON DUTY
NOTIFYING PATIENT OR CAREGIVER
NOTIFYING PRESCRIBER
COMMUNICATING DIRECTIONS TO CORRECT THE ERROR
COMMUNICATING INSTRUCTIONS FOR MINIMIZING ANY NGATIVE IMPACT
🗑
|
||||
| CQI RECORDS | show 🗑
|
||||
| show | AUTHORIZED PHARMACIST MEANS IOWA LICENSED PHARMACIST WHO HAS MET THE REQUIREMENTS
🗑
|
||||
| WHAT ARE THE REQUIREMENTS FOR VACCINE ADMINISTRATION | show 🗑
|
||||
| show | PROTOCOL SIGNED BY LICENSED IOWA PRESCRIBER
SHALL EXPIRE NO LATER THAN 1 YEAR FROM EFFECTIVE DATE
BE EFFECTIVE FOR PATIENTS WHO HAVE NO CONTRAINDICATIONS AND MEET CDC (CENTRE FOR DISEASE CONTROL AND PREVENTION) CRITERIA
🗑
|
||||
| IN CASE OF SERIOUS COMPLICATION RE VACCINE ADMINISTRATION | show 🗑
|
||||
| if closing pharmacy -notify who -time frame | show 🗑
|
||||
| show | RX DRUGS TRANSFERED-COMPLETE INVENTORY AS OF CLOSE OF BUSINESS.=ENDING INVENTORY =ADDITIONAL OR STARTING INVENTORY FOR RECEIVING PHARMACY
🗑
|
||||
| CLOSING PHARMACY - INVENTORY (CONT.) | show 🗑
|
||||
| show | RECORDS PERTAINING TO TRANSFER OF CS -SELLER TO BUYER- ON THE DATE OF SALE
🗑
|
||||
| show | WITHING 10 DAYS -RETURN PHARMACY LICENSE CERTIFICATE, STATE CSA REGISTRATION CERTIFICATE- TO BOARD
WITHIN 10 DAYS- RETURN DEA CERTIFICATE, UNUSED DEA CII ORDER FORMS(DEA222) - TO DEA OFFICE
🗑
|
||||
| CLOSING PHARMACY | show 🗑
|
||||
| show | PHARMACEUTICAL CARE- PROMOTE HEALTH,PREVENT DISEASE,OPTIMIZE DRUG THERAPY,
DRUG THERAPY PROBLEMS-IDENTFY,PREVENT,RESOLVE
DRUG THERAPY PLAN-ASSESS ,EVALUATE,MONITOR,SUGGEST
🗑
|
||||
| PHARMACY OPERATIONS - RESPONSIBILITY | show 🗑
|
||||
| PRACTICE FUNCTIONS, VERIFICATIONS | show 🗑
|
||||
| show | PHARMACY SUPPORT PERSON
🗑
|
||||
| show | DISPLAY VIVBLE TO PUBLIC ORIGINAL LICENSE AND CERTIFICATES OF RENEWAL (COPY) ,BADGE=FIRST NAME,PHARMACIST
🗑
|
||||
| show | PERMANENT LOG OF INITIALS OR ID CODES KEPT FOR MIN 2 YEARS, AVAIL FOR BOARD INSPECTIONS, FOR TEMPORARY STAFF-DATES AND SHIFTS WORKED ALSO.
APPLIES TO RXT,INTERNS,TECHS,PSP
🗑
|
||||
| show | REFRIGIRATION-WITH THERMOMETER
SINK WITH HOT/COLD WATER
LOCATED WITHING PHARMACY
DEPARTMENT
SECURE BARRIER IN ABSENCE
OF RXT
LIGHT,VENTILATION,TEMPERATURE,
HUMIDITY-
MAINTAINED
TO PROPER STORE DRUGS
ORDERLY AND CLEAN
🗑
|
||||
| BULK COUNTING MACHINES | show 🗑
|
||||
| show | NOTIFY BOARD AT LEAST 30 DAYS PRIOR TO COMMENCEMENT (APPLIES TO PREMISES CURRENTLY OCCUPIED OR INSTALLATION OF STERILE COMPOUNDING FACILITY) PRIOR OR DURING OR AT TEMPORARY LOCATION- ON SITE INSPECTION BY BOARD MAY BE REUIRED
🗑
|
||||
| show | DIFENOXIN (LYSPAFEN)
HEROIN(DIACETHYLMORPHIN)
MARIJUANA
LSD (LYSERGIC ACID DIETHYLAMIDE)
PEYOTE
DIHYDROMORPHINE
MESCALINE
🗑
|
||||
| show | ALPRAZOLAM(XANAX)
STADOL,TORBUGESIC,TORBUTROL(BUTORPHANOL)
CHLORALHYDRATE(NOCTEC)
CLONAZEPAM(CLONOPIN)
BARBITAL(BARBITONE)
CHLORDIAZEPOXIDE(LIBRIUM,SK-LYGEN)
DIAZEPAM(VALIUM, VALRELEASE)
CLORAZEPATE(TRANXENE)
REDUX(DEXFENFLURAMINE)
🗑
|
||||
| show | PROPOXIFEN WITH OTHER INGREDIENTS:(DARVON,DALENE,PROPOCET,DARVOCET)
DICHLORALPHENAZONE(MIDRIN)
MOTOFEN(ATROPIN 25MCG/DIFENOXIN 1MG
ESTAZOLAM(PROSOM, DOMNAMID,EURODIN,NUCTALON)
ETHCHLORVYNOL(PLACIDYL)
FENFLURAMINE(PONDIMIN,PONDERAL)
🗑
|
||||
| C-IV CONT | show 🗑
|
||||
| C-IV CONT | show 🗑
|
||||
| show | ALFENTANIL(ALFENTA)
AMOBARBITAL(AMYTAL,TUINAL)
COCA LEAVES
COCAINE
AMPHETHAMINE(DEXEDRINE,BIPHETAMINE)
CODEINE
DEXTROPROPOXIPHENE,BULK NON DOSAGE FORM
DIHYDROCODEINE(DIDRATE,PARZONE)
DIPHENOXYLATE
FENTANYL(SUBLIMAZE,DURAGEZIC,INNOVAR)
🗑
|
||||
| C-II CONT | show 🗑
|
||||
| C-II CONT | show 🗑
|
||||
| C-II CONT | show 🗑
|
||||
| AMDS -AUTOMATED MEDICATION DISTRIBUTION SYSTEMS | show 🗑
|
||||
| AUTOMATED PHARMACY SYSTEM | show 🗑
|
||||
| show | LOCATED IN THE PHARMACY
🗑
|
||||
| DECENTRALIZED AMDS | show 🗑
|
||||
| OUTPATIENT AMDS | show 🗑
|
||||
| show | LICENSED PHARMACY STAFFED BY ONE OR MORE QUALIFIED CERTIFIED PHARMACY TECHNICIANS AT WHICH TELEPHARMACY SERVICES ARE PROVIDED THROUGH A LICENSED MANAGING PHARMACY
🗑
|
||||
| WHO IS IN CHARGE OF THE REMOTE SITE | show 🗑
|
||||
| RESPONSIBILITIES OF PIC - AMDS | show 🗑
|
||||
| show | PIC
🗑
|
||||
| NOTIFICATION TO THE BOARD- RE: AMDS | show 🗑
|
||||
| NOTICE TO THE BOARD RE AMDS SHOULD INCLUDE: | show 🗑
|
||||
| show | MANAGING PHARMACY - GENERAL PHARMACY LICENSE
REMOTE DISPENSING SITE- LIMITED PHARMACY LICENSE (IT IS CONSIDERED AN EXTENSION OF MANAGING PHARMACY)
🗑
|
||||
| show | NOT APPROVED IF WITHING SAME COMMUNITY OR 15 MILES OF MANAGING PHARMACY
CONSIDER NEED FOR THIS SERVICE AND AVAILABILITY OF PHARMACISTS
🗑
|
||||
| INSPECTIONS OF AMDS | show 🗑
|
||||
| HOW OFTEN TO TEST AMDS | show 🗑
|
||||
| RANDOM VERIFICATION BY A PHARMACIST (DECENTRALIZED AMDS) | show 🗑
|
||||
| show | INCORRECT DRUG, DOSE, DOSAGE FORM ,OTHER ERRORS(INCLUDE DESCRIPTIONS)
🗑
|
||||
| CATEGORIES OR ERRORS IDENTIIED IN CENTRALIZED AMDS | show 🗑
|
||||
| DO THESE AMDS ERRORS HAVE TO BE SUBMITTED TO THE BOARD? | show 🗑
|
||||
| show | IF THE AVERAGE ACCURACY DURING INITIAL 60 DAYS IS 99.7% FOR ALL DRUG DOSES DISPENSED
🗑
|
||||
| RANDOM VERIFICATION BY PHARMACIST (CENTRALIZED AMDS) | show 🗑
|
||||
| IF AVERAGE ACCURACY OF AMDS IS NOT 99.7% FOR THE INITIAL 60 DAY PERIOD? | show 🗑
|
||||
| show | 1ST YEAR - QUARTERLY,AFTER 1 YEAR WHEN ACCURACY LESS THAN 99.7%
WRITTEN REPORT INCLUDING CORRECTIVE ACTIONS
🗑
|
||||
| OUTPATIENT AMDS- VERIFICATION AND REPORTING | show 🗑
|
||||
| REPORT ERRORS ID IN OUTPATIENT AMDS: | show 🗑
|
||||
| show | NO, ALL ORAL RX ORDERS SHOULD BE COMMUNICATED TO THE PHARMACIST
🗑
|
||||
| RX LABEL INFO FROM REMOTE SITE | show 🗑
|
||||
| show | LABEL AS SUCH:
ATORVSTATIN, GENERIC FOR LIPITOR (BRAND)
🗑
|
||||
| show | LABEL AS SUCH:
LIPITOR FOR ATORVASTATIN
🗑
|
||||
| RECORDS AT REMOTE SITE - | show 🗑
|
||||
| C-III | show 🗑
|
||||
| show | BUTABARBITAL( BUTISOL,BUTIBEL)
BUTALBITAL(FIORINAL, BUTALBITAL WITH ASA)
CODEINE AND ISOQUINOLINE ALCALOID (CODEINE WITH PAPAVERIN OR NOSCAPINE)
CODEINE COMBINATION PRODUCTS (EMPIRIN, FIORINAL, TYLENOL ,ASA WITH CODEINE)
🗑
|
||||
| C-III CONT | show 🗑
|
||||
| show | NANDROLONE (DECABOLIN,DECA-DURABOLIN,DURABOLIN-50)
METHYLTESTOSERONE (ANDROID,VIRILON,TESTRED,ORETON)
NALORPHINE (NALLINE)
NORETHANDROLONE(NILEVAR,SOLEVAR)
🗑
|
||||
| show | OPIUM COMBINATION(PAREGORIC)
PENTOBARBITAL AND NON CONTROLLED INGRIDIENTS
PENTOBARBITAL SUPPOSITORY
PHENDIMETRAZIL(BONTRIL)
SECOBARBITAL WITH NON CONTROLLED
SECOBARBITAL SUPPOSITORY
TESTOSTERONE(ANDROID-T, ANDROLAN,DEPOTEST,DELATESTRYL)
🗑
|
||||
| show | SEPARATE CS REGISTRATION REQUIRED FOR EACH LOCATION OF PRACTICE
🗑
|
||||
| DOCTOR WITH PRIVATE OFFICE WORKING AT A HOSPITAL- HOW MANY CS REGISTRATIONS? | show 🗑
|
||||
| show | CS C-I SHALL BE STORED IN SECURELY LOCKED SUBSTANTIALLY CONSTRUCTED CABINET
CS C-II TO V MAY BE STORED IN SECURELY LOCKED SUBSTANTIALLY CONSTRUCTED CABINET OR MAY BE MIXED THROUGHOUT THE STOCK OF NONCONTROLLED SUBSTANCES TO OBSTRUCT THEFT OR DIVERSION
🗑
|
||||
| WHEN AND WHERE TO REPORT THEFT OR LOSS | show 🗑
|
||||
| WHAT CAN BE ADDED BY A PHARMACIST TO CS RX? | show 🗑
|
||||
| show | PATIENT'S NAME
CS PRESCRIBED (EXCEPT FOR GENERIC SUBSTITUTION
NAME OR SIGNATURE OF PRESCRIBER
🗑
|
||||
| show | DUE TO SHORT SUPPLY - WITHING 72 HOURS, AFTER 72 HRS- ONLY NEW RX
FOR LTCF-OR TERMINALLY ILL- 60 DAYS
🗑
|
||||
| show | IN MULTIPLE RX WITH START DATES FOR UP TO 90 DAYS
🗑
|
||||
| show | PRESCRIBER CAN CALL OR FAX C-II RX
PHARMACIST PREPARES WRITTEN OR PRINTED RECORD
PHARMACIST RESPONSIBLE FOR VERIFYING PRESCRIBER IF NOT KNOWN
DOCTOR RESPONSIBLE FOR PROVIDING WRITTEN SIGNED RX FOR EMERGENCY QTY TO BE DELIVERED TO PHARMACIST
🗑
|
||||
| show | IMMEDIATE ADMIN REQUIRED
NO APPROPRIATE ALTERNATIVE AVAILABLE
PRESCRIBER UNABLE TO PROVIDE ELECTRONIC OR MANUALLY SIGNED WRITTEN RX
🗑
|
||||
| WHAT ADDITIONAL INFO WRITTEN ON THE FACE OF WRITTEN RX FOR EMERGENCY QTY? | show 🗑
|
||||
| IF WRITTEN RX FOR EMERGENCY SUPPLY IS NOT DELIVERED WITHING 7 DAYS? | show 🗑
|
||||
| CAN YOU REFILL C-II RX ? | show 🗑
|
||||
| CAN YOU ALTER AUTHORIZED FILL DATES? | show 🗑
|
||||
| HOW MANY MULTIPLE RXS FOR CONSECUTIVE FILLING ARE ALLOWED? | show 🗑
|
||||
| CAN I FILL RX FAXED TO PHARMACY FOR C-III -V? | show 🗑
|
||||
| show | YES, BUT TOTAL QTY INCLUDING ORIGINAL RX SHOULD NOT EXCEED 6 MONTH SUPPLY AND NOT BE REFILLED MORE THAN 5 TIMES
🗑
|
||||
| show | PHARMACIST OR INTERN UNDER SUPERVISION
🗑
|
||||
| show | YES, BUT ONLY AFTER PHARMACIST FULFILLED PROFESSIONAL AND LEGAL RESPONSIBILITIES
🗑
|
||||
| WHEN SELLING C-V OTC ,RECORD WHAT? | show 🗑
|
||||
| SELLING PSE,EPHEDRINE, PHENYLPROPANOLAMIE OTC - WHO CAN SELL AND HOW TO RECORD? | show 🗑
|
||||
| WHAT PTS RECORD SHALL CONTAIN? | show 🗑
|
||||
| WHAT ELSE IS REQUIRED IN THE PHARMACY CONCERNING SALE OF PSE,PPA,EPHE? | show 🗑
|
||||
| INVENTORY OF C-II- HOW OFTEN AND HOW LONG TO KEEP RECORD OF? | show 🗑
|
||||
| show | PERPETUAL INVENTORY RECORD- MATCH ALL DRUGS RECIEVED WITH ALL RX FILLED - IF DISCREPANCY -NOTIFY PIC.
PHYSICAL INVENTORY COUNT - ONCE A YEAR. RECORDS SHOULD MATCH/RECONCILED WITH PERPETUAL INVENTORY. MUST INCLUDE ID OF INDIVIDUAL PERFORMING INVENTORY
🗑
|
||||
| show | BROWN+GREEN (SUPPLIER +DEA) -& BLUE(PURCHASER)
🗑
|
||||
| INVENTORY OF C-I AND C-II AND HYDROCODONE (SOLID ORAL,INJECTABLE ) | show 🗑
|
||||
| INVENTORY C-III,IV,V | show 🗑
|
||||
| show | 1.PREPARED ACCORDING TO LABELED INSTRUCT.EXPOSE TO POTENTIAL CONTAMIN.
2.CONTAINS NONSTERILE ING THAT MUST BE STERILIZED BEFORE ADMIN
3. BIOLOGIC,DIAGNOSTIC OR OTHER THAT REQ.TO BE STERILE WHEN ADMINISTERED
🗑
|
||||
| ANTE AREA | show 🗑
|
||||
| ASEPTIC PROCEDURE | show 🗑
|
||||
| BIOLOGICAL SAFETY CABINET | show 🗑
|
||||
| show | BASED ON RELIABLE LITERATURE SOURCES, MAINTAIN WRITTEN JUSTIFICATION OF STANDARDS OR, IF NOT AVAIL.-24 HOUR EXPIRY DATE
🗑
|
||||
| ADDITIONAL REFERENCE REQUIREMENT FOR COMPOUNDING STERILE PRODUCTS | show 🗑
|
||||
| EXTRA PROCEDURE REQUIRED IN STERILE COMPOUNDING | show 🗑
|
||||
| POLICIES AND PROCEDURES MANUAL | show 🗑
|
||||
| show | QUALITY ASSURANCE PROGRAM, SAMPLING, PREPARATION RECALL,HAZARDOUS PRODUCTS AND INFECTIOUS WASTE.
HAS TO BE AVAILABLE FOR PERIODIC REVIEWS AND INSPECTION BY THE BOARD
🗑
|
||||
| LABEL REQUIREMENTS FOR STERILE PREPARTION | show 🗑
|
||||
| show | NAME AND QUANTITY OF ALL CONTENTS, INTERNAL CODE IDENTIFYING DATE AND TIME OF PREPARATION, AND UNIQUE ID OF PREPARER'S AND PHARMACIST'S, STABILITY,AUX LABELS
🗑
|
||||
| show | ISO-5,3 OR LESS PRODUCTS,2 OR LESS ENTITIES(BAGS,VIALS) PREPARED BY OPENING AMPULE, PENETRATING STOPPER WITH STERILE NEEDLE AND TRANSFERRING TO ANOTHER FOR ADMIN.
🗑
|
||||
| STORAGE CONDITIONS FOR LOW RISK | show 🗑
|
||||
| show | MANUAL MEASURING AND MIXING 3 OR LESS MANUFACTURED PRODUCTS INCLUDING INF USION OR DILUTENT TO COMPOUND NUTRITIONAL SOLUTIONS
🗑
|
||||
| show | ADMINISTRATION SHALL COMMENCE WITHING 12 HOURS OF THE START OF COMPOUNDING
🗑
|
||||
| show | COMPOUNDED ASEPTICALLY UNDER LOW RISK CONDITIONS -MULTIPLE OR SMALL DOSES OF STERILE PRODUCTS ,MULTIPLE ADMINISTRATIONS OR MULTIPLE PATIENTS.
COMPLEX ASEPTIC MANIPULATIONS, LONG PROCESS
🗑
|
||||
| show | ROOM 30HOURS, COLD FOR 9 DAYS, SOLID FROZEN -25C FOR 45 DAYS
🗑
|
||||
| EXAMPLES OF MEDIUM RISK | show 🗑
|
||||
| show | PREPARATIONS THAT EITHER ARE CONTAMINATED OR AT RISK TO BE WHEN COMPOUNDED AND REQUIRES TERMINAL STERILIZATION
🗑
|
||||
| STORAGE CONDITIONS FOR HIGH RISK | show 🗑
|
||||
| IMMEDIATE USE STERILE PREPARATIONS | show 🗑
|
||||
| WHERE IMMEDIATE USE PREPARATIONS ARE UTILIZED? | show 🗑
|
||||
| show | VERTICAL FLOW CLASS II OR CLASS III BIOLOGICAL SAFETY CABINET (BSC) OR COMPOINDING SAFETY ISOLATOR (CAI)
🗑
|
||||
| POLICIES AND PROCEDURES FOR HAZ DRUGS PREP INCLUDE.. | show 🗑
|
||||
| PHARMACISTS VERIFICATION OF STERILE COMPOUNDS MUST INCLUDE.. | show 🗑
|
||||
| MEDIA-FILL TESTING BY PERSONNEL PERFORMED | show 🗑
|
||||
| HOW OFTEN CLEAN ROOMS, LAMINAR AIRFLOW HOODS AND BARRIER ISOLATORS NEED TO BE CERTIFIED | show 🗑
|
||||
| show | AIR SAMPLING AND PRESSURE DIFFERENTIAL MONITORING
🗑
|
||||
| show | LICENSED IN IOWA, MEET MIN STANDARDS OF TRAINING FOR MED USES OF RADIOACTIVE MATERIALS - SUBMIT AFFIDAVIT OF IT TO BOARD. COMPLETE 90 HRS COLLEGE TRAINING+160 hrs practical CLINICAL training .COMPLETE RESIDENCY.COMPLETE CERTIFICATE PROGRAM (ACPE)
🗑
|
||||
| show | LICENSED IN IOWA, CERTIFIED BY BOARD OF PHARMACEUTICAL SPECIALTIES AS A BOARD CERTIFIED NUCLEAR PHARMACIST (BCNP) -SUBMIT AFFIDAVIT TO BOARD
🗑
|
||||
| show | AT LEAST 25 FT SQUARE SEPARATE FROM NON RADIOACTIVE DRUGS FOR STORAGE AND PRODUCT DECAY
🗑
|
||||
| ADDITIONAL LABELS FOR INNER IMMEDIATE CONTAINER OF A RADIOACTIVE DRUG | show 🗑
|
||||
| ADDITIONAL LABELS FOR OUTER CONTAINER | show 🗑
|
||||
| show | LAMINAR FLOW HOOD,
DOSE CALIBRATOR,
REFRIGERATOR,
SINGLE CHANNEL SCINTILLATION
COUNTER,
MICROSCOPE,
AUTOCLAVE,INCUBATOR
,RADIATION SURVEY METER.
🗑
|
||||
| IF A PHARMACISTS LICENSE IS SUSPENDED, SURRENDERED OR REVOKED ,WHEN CAN APPLICATION BE MADE TO REINSTATE | show 🗑
|
||||
| WHAT IS REQUIRED TO REINSTATE LICENSE? | show 🗑
|
||||
| show |
🗑
|
||||
| show |
🗑
|
||||
| LABELING AND RECORDING OF POISONS | show 🗑
|
||||
| show |
🗑
|
||||
| show |
🗑
|
||||
| DOCTOR WRITES RX FOR OTC PRODUCTS WITH DIFFERENT INSTRUCTIONS FROM THE BOX | show 🗑
|
||||
| show |
🗑
|
||||
| IF OTC REPACKAGED - WHAT ARE LABELING REQUIREMENTS | show 🗑
|
||||
| show |
🗑
|
||||
| INVESTIGATIONAL STATUS DRUGS - WHO CAN GIVE TO PATIENTS.. | show 🗑
|
||||
| show |
🗑
|
||||
| GENERAL PRACTITIONER WROTE RX FOR METHADONE FOR ADDICTION TREATMENT- IS IT ILLEGAL? | show 🗑
|
||||
| I pass!!!!! no need to fill the rest:)):)) | show 🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
irina123
Popular Standardized Tests sets